Novel coronavirus pneumonia is currently in an epidemic stage and is classified as a category B infectious disease in China and is managed according to category A. In China’s current treatment policy for novel coronavirus pneumonia, the current policy may vary from region to region, but in Beijing, for example, generally speaking, if there is medical insurance to cover part of the costs, the remaining costs are borne by the state. In the case of patients who are completely self-paying, at this stage, the cost of treatment does not need to be paid by the patient. Therefore, if you are unfortunate enough to be infected with novel coronavirus pneumonia, you do not have to worry too much about the cost of treatment. According to the existing policy implementation regulations, there may be possible differences in different regions, which is subject to the specific local policy. Content source: Dr. You Lai